As of 2025-03-21, the Relative Valuation of Creo Medical Group PLC (CREO.L) is (124.09) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 12.80 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is -1069.5%.
The range of the Relative Valuation is (97.21) - (134.14) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 24.7x | 21.3x |
| Forward P/E multiples | 17.2x - 31.6x | 24.4x |
| Fair Price | (97.21) - (134.14) | (124.09) |
| Upside | -859.4% - -1147.9% | -1069.5% |
| Date | P/E |
| 2025-03-18 | -2.36 |
| 2025-03-17 | -2.37 |
| 2025-03-14 | -2.42 |
| 2025-03-13 | -2.42 |
| 2025-03-12 | -2.51 |
| 2025-03-11 | -2.51 |
| 2025-03-10 | -2.55 |
| 2025-03-07 | -2.55 |
| 2025-03-06 | -2.51 |
| 2025-03-05 | -2.55 |
| 2025-03-04 | -2.62 |
| 2025-03-03 | -2.69 |
| 2025-02-28 | -2.65 |
| 2025-02-27 | -2.74 |
| 2025-02-26 | -2.74 |
| 2025-02-25 | -2.69 |
| 2025-02-24 | -2.74 |
| 2025-02-21 | -2.88 |
| 2025-02-20 | -2.97 |
| 2025-02-19 | -2.92 |
| 2025-02-18 | -3.08 |
| 2025-02-17 | -3.13 |
| 2025-02-14 | -3.48 |
| 2025-02-13 | -3.54 |
| 2025-02-12 | -3.64 |
| 2025-02-11 | -3.59 |
| 2025-02-10 | -3.50 |
| 2025-02-07 | -3.50 |
| 2025-02-06 | -3.41 |
| 2025-02-05 | -3.30 |
| 2025-02-04 | -3.31 |
| 2025-02-03 | -3.36 |
| 2025-01-31 | -3.31 |
| 2025-01-30 | -3.31 |
| 2025-01-29 | -3.31 |
| 2025-01-28 | -3.39 |
| 2025-01-27 | -3.45 |
| 2025-01-24 | -3.46 |
| 2025-01-23 | -3.31 |
| 2025-01-22 | -3.20 |
| 2025-01-21 | -3.31 |
| 2025-01-20 | -3.41 |
| 2025-01-17 | -3.41 |
| 2025-01-16 | -3.50 |
| 2025-01-15 | -3.50 |
| 2025-01-14 | -3.41 |
| 2025-01-13 | -3.36 |
| 2025-01-10 | -3.35 |
| 2025-01-09 | -3.59 |
| 2025-01-08 | -3.64 |